Steel,/Homorelaps480222.html,Mesh,,$47,Advantech,8",laagvlieger.x24hr.com,Sieves,,#120,Test,Industrial Scientific , Lab Scientific Products , Lab Supplies Consumables,F,Diameter,,Stainless $47 Advantech Stainless Steel Test Sieves, 8" Diameter, #120 Mesh, F Industrial Scientific Lab Scientific Products Lab Supplies Consumables Steel,/Homorelaps480222.html,Mesh,,$47,Advantech,8",laagvlieger.x24hr.com,Sieves,,#120,Test,Industrial Scientific , Lab Scientific Products , Lab Supplies Consumables,F,Diameter,,Stainless Advantech Stainless Steel Test Sieves Rapid rise Diameter F 8" Mesh #120 $47 Advantech Stainless Steel Test Sieves, 8" Diameter, #120 Mesh, F Industrial Scientific Lab Scientific Products Lab Supplies Consumables Advantech Stainless Steel Test Sieves Rapid rise Diameter F 8" Mesh #120

Advantech Stainless Steel Test Sieves Rapid rise Diameter Max 57% OFF F 8

Advantech Stainless Steel Test Sieves, 8" Diameter, #120 Mesh, F

$47

Advantech Stainless Steel Test Sieves, 8" Diameter, #120 Mesh, F

|||

Product description

Size:8 Inches Diameter, Full Height

The Advantech #120 test sieve has stainless steel walls and mesh, and is used for heavy-duty sieving applications. The #120 mesh filters particles up to 125 micron/0.125mm. The depth of the wall to the wire cloth includes a choice of full height (3-1/4" depth), intermediate height (2" depth), or half height (1-5/8" depth). The sieve is etched with a serial number traceable to NIST standards. It includes a Certificate of Compliance to ASTM International E11 specifications. The stainless steel walls and mesh are suitable for heavy-duty applications and is heat-resistant. Test Sieves are used to measure particle size, and in other quality control applications.

Advantech Stainless Steel Test Sieves, 8" Diameter, #120 Mesh, F

CURRENT ISSUE
September, 2021

No. 106 (9)

2020 Impact Factor: 9.941 Submission > Acceptance: 52 days
ARTICLES IN THREE SENTENCES
Article

Long-term outcomes from the phase II L-MIND study of tafasitamab (MOR208) plus lenalidomide in patients with relapsed or refractory diffuse large B-cell lymphoma

This open-label, single-arm study investigated the long-term efficacy of tafasitamab plus lenalidomide in 81 patients with relapsed/refractory diffuse large B-cell lymphoma. The response rate was 57.5%, including complete responses in 40.0% of patients, and the median duration of response was 43.9 months. This treatment is a valuable option for patients not eligible for autologous stem-cell transplantation.

Johannes Duell et al.

Case Report

Clinical genomic profiling of novel grey zone lymphoma paired lesions with sequential central nervous system involvement in two adolescent patients

Grey zone lymphoma is a B-cell lymphoma, unclassifiable, with features intermediate between those of large B-cell lymphoma and classic Hodgkin lymphoma. The in-depth study of the two adolescent patients described in this case report expands the clinicopathological and genomic spectrum of this rare pediatric disease. Moreover, it provides information on their response to treatment.

Cagla Y. Benkli et al.

Article

CAMT-MPL: congenital amegakaryocytic thrombocytopenia caused by MPL mutations - heterogeneity of a monogenic disorder - a comprehensive analysis of 56 patients

The clinical picture of 56 patients with congenital amegakaryocytic thrombocytopenia due to MPL mutations was much more varied than previously thought. Twenty-five per cent of them had no signs of thrombocytopenia at birth, and 50% had non-hematologic defects. Pancytopenia developed in (nearly) all patients and hematopoietic stem-cell transplantation was effective in 87% of cases.

Manuela Germeshausen et al.

Article

Oxidative stress activates red cell adhesion to laminin in sickle cell disease

Sickle red blood cells exhibit abnormal adhesion to laminin mediated by Lu/BCAM protein at their surface. This study provides evidence of the involvement of oxidative stress in post-translational modifications of Lu/BCAM which impact the protein’s distribution and cis-interaction with glycophorin C at the cell surface activating its adhesive function in dense sickle red cells. The authors speculate that antioxidant drugs might attenuate this phenomenon.

Maria Alejandra Lizarralde-Iragorri et al.

TAKE ADVANTAGE FROM HAEMATOLOGICA